Scientific rationale for the inclusion and exclusion criteria for intravenous alteplase in acute ischemic stroke: a statement for healthcare professionals from the …
BM Demaerschalk, DO Kleindorfer, OM Adeoye… - Stroke, 2016 - Am Heart Assoc
Purpose—To critically review and evaluate the science behind individual eligibility criteria
(indication/inclusion and contraindications/exclusion criteria) for intravenous recombinant …
(indication/inclusion and contraindications/exclusion criteria) for intravenous recombinant …
Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke …
G Saposnik, F Barinagarrementeria, RD Brown Jr… - Stroke, 2011 - Am Heart Assoc
Background—The purpose of this statement is to provide an overview of cerebral venous
sinus thrombosis and to provide recommendations for its diagnosis, management, and …
sinus thrombosis and to provide recommendations for its diagnosis, management, and …
Antithrombotic therapy in neonates and children: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians Evidence-Based Clinical …
Background Neonates and children differ from adults in physiology, pharmacologic
responses to drugs, epidemiology, and long-term consequences of thrombosis. This …
responses to drugs, epidemiology, and long-term consequences of thrombosis. This …
Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific …
Methods A writing group was established with representation from the Council on Peripheral
Vascular Disease and Council on Cardiopulmonary, Critical Care, Perioperative and …
Vascular Disease and Council on Cardiopulmonary, Critical Care, Perioperative and …
Dramatic increase in venous thromboembolism in children's hospitals in the United States from 2001 to 2007
L Raffini, YS Huang, C Witmer, C Feudtner - Pediatrics, 2009 - publications.aap.org
OBJECTIVES: The goals were to determine whether there has been an increase in the rate
of venous thromboembolism (VTE) in pediatric tertiary care hospitals and to evaluate the use …
of venous thromboembolism (VTE) in pediatric tertiary care hospitals and to evaluate the use …
Arterial ischemic stroke risk factors: the International Pediatric Stroke Study
MT Mackay, M Wiznitzer, SL Benedict… - Annals of …, 2011 - Wiley Online Library
Objective To describe presumptive risk factors (RFs) for childhood arterial ischemic stroke
(AIS) and explore their relationship with presentation, age, geography, and infarct …
(AIS) and explore their relationship with presentation, age, geography, and infarct …
Epidemiology and pathophysiology of nephrotic syndrome–associated thromboembolic disease
After infections, thromboembolism is considered by many experts to be the most significant
life-threatening complication of nephrotic syndrome. The purpose of this review is to …
life-threatening complication of nephrotic syndrome. The purpose of this review is to …
Management of occlusion and thrombosis associated with long-term indwelling central venous catheters
JL Baskin, CH Pui, U Reiss, JA Wilimas, ML Metzger… - The Lancet, 2009 - thelancet.com
Long-term central venous catheters (CVCs) are important instruments in the care of patients
with chronic illnesses, but catheter occlusions and catheter-related thromboses are common …
with chronic illnesses, but catheter occlusions and catheter-related thromboses are common …
Effect of anticoagulant therapy for 6 weeks vs 3 months on recurrence and bleeding events in patients younger than 21 years of age with provoked venous …
NA Goldenberg, JM Kittelson, TC Abshire, M Bonaca… - Jama, 2022 - jamanetwork.com
Importance Among patients younger than 21 years of age, the optimal duration of
anticoagulant therapy for venous thromboembolism is unknown. Objective To test the …
anticoagulant therapy for venous thromboembolism is unknown. Objective To test the …
Prevention and treatment of thrombosis in pediatric and congenital heart disease: a scientific statement from the American Heart Association
TM Giglia, MP Massicotte, JS Tweddell, RJ Barst… - Circulation, 2013 - Am Heart Assoc
Thrombosis has long been recognized as a potentially lifethreatening complication in
children with congenital heart disease (CHD), children with acquired heart disease, and in …
children with congenital heart disease (CHD), children with acquired heart disease, and in …